drugset / Trial / NCT00162266
Abatacept With Methotrexate- Phase IIB
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was conducted to assess the safety and tolerability of Abatacept combined with Methotrexate in participants with active rheumatoid arthritis (RA). The secondary objectives were to assess efficacy, pharmacodynamic marker activity, and immunogenicity of Abatacept combined with Methotrexate.
Timeline
- Start
- 2000-10
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | 2 mg/kg | Intravenous |
| Subject | Abatacept | Other / unclassified | 10 mg/kg | Intravenous |